Endo Pharmaceuticals Inc
Endo | A Global Specialty Pharmaceutical Company.
Employees
Share price
$0.29 ENDP
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $171m | Post IPO Equity |
| Total Funding | 000k | ||
Signet Healthcare Partners(exited)
New Leaf Venture Partners(exited)
| USD | 2024 | 2025 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | (4 %) |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Endo Pharmaceuticals Inc
EditACQUISITION by Endo Pharmaceuticals Inc Aug 2014
ACQUISITION by Knight Therapeutics Mar 2025
ACQUISITION by Endo Pharmaceuticals Inc Sep 2014
ACQUISITION by Endo Pharmaceuticals Inc May 2015
ACQUISITION by Endo Pharmaceuticals Inc Aug 2010
ACQUISITION by Endo Pharmaceuticals Inc Oct 2020
ACQUISITION by Endo Pharmaceuticals Inc Sep 2010
ACQUISITION by Endo Pharmaceuticals Inc Jan 2009